Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Downes

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Cancer Research|September 15, 2020
Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the PancreasElizabeth Lenkiewicz, Smriti Malasi, Tara L Hogenson, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Chronic pancreatitis patient-derived organoids reveal new paths to precision therapeuticsVictoria Osorio-Vasquez, Jonathan Zhu, Jan C Lumibao, et al.
JCI Insight|September 26, 2024
The human milk oligosaccharide 3'sialyllactose reduces low-grade inflammation and atherosclerosis development in miceAriane R Pessentheiner, Nathanael J Spann, Chloe A Autran, et al.
Nature|April 19, 2019
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoringYu Shi, Weina Gao, Nikki K Lytle, et al.
Gastroenterology|April 24, 2022
Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular MetabolismJinhyuk Choi, Tae Gyu Oh, Hee-Won Jung, et al.
Nature|December 1, 2021
Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoringYu Shi, Weina Gao, Nikki K Lytle, et al.
Cell Stem Cell|June 30, 2026
Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitisVictoria Osorio-Vasquez, Jonathan Zhu, Jan C Lumibao, et al.
Nature Communications|September 6, 2023
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancerCorina E Antal, Tae Gyu Oh, Stefan Aigner, et al.
Nature Cancer|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trialKimberly J Perez, Andressa Dias Costa, Alexander Jordan, et al.
Nature|March 31, 2022
Obesity alters pathology and treatment response in inflammatory diseaseSagar P Bapat, Caroline Whitty, Cody T Mowery, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Cancer Research|September 15, 2020
Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the PancreasElizabeth Lenkiewicz, Smriti Malasi, Tara L Hogenson, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Chronic pancreatitis patient-derived organoids reveal new paths to precision therapeuticsVictoria Osorio-Vasquez, Jonathan Zhu, Jan C Lumibao, et al.
JCI Insight|September 26, 2024
The human milk oligosaccharide 3'sialyllactose reduces low-grade inflammation and atherosclerosis development in miceAriane R Pessentheiner, Nathanael J Spann, Chloe A Autran, et al.
Nature|April 19, 2019
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoringYu Shi, Weina Gao, Nikki K Lytle, et al.
Gastroenterology|April 24, 2022
Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular MetabolismJinhyuk Choi, Tae Gyu Oh, Hee-Won Jung, et al.
Nature|December 1, 2021
Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoringYu Shi, Weina Gao, Nikki K Lytle, et al.
Cell Stem Cell|June 30, 2026
Patient-derived organoids reveal ductal dysfunction and CFTR-modulator responses in chronic pancreatitisVictoria Osorio-Vasquez, Jonathan Zhu, Jan C Lumibao, et al.
Nature Communications|September 6, 2023
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancerCorina E Antal, Tae Gyu Oh, Stefan Aigner, et al.
Nature Cancer|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trialKimberly J Perez, Andressa Dias Costa, Alexander Jordan, et al.
Nature|March 31, 2022
Obesity alters pathology and treatment response in inflammatory diseaseSagar P Bapat, Caroline Whitty, Cody T Mowery, et al.
Pageof 19